- Trials with a EudraCT protocol (112)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
112 result(s) found for: Haemodialysis.
Displaying page 1 of 6.
EudraCT Number: 2005-003148-79 | Sponsor Protocol Number: 08/05 | Start Date*: 2006-03-21 |
Sponsor Name:Wirral Hospitals NHS Trust | ||
Full Title: Role of antibiotic line locks in the prevention of tunnelled haemodialysis catheter infection: a double blind randomised controlled trial. | ||
Medical condition: Tunnelled haemodialysis catheter related infection. These infections are common (approximately 2-7 infections per 1000 catheter days) in patients on haemodialysis; we aim to assess the efficacy of ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004702-56 | Sponsor Protocol Number: NN1630-1453 | Start Date*: 2007-08-07 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Outcome Trial Evaluating the Efficacy and Safety of Norditropin® in Adult Patients on Chronic Haemodialysis A Randomised, Double-blind, Parallel group, placebo controlled, Multi-centre trial | |||||||||||||
Medical condition: Adult Patients in Chronic Dialysis (APCD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) FR (Completed) ES (Completed) DE (Prematurely Ended) IT (Prematurely Ended) PT (Prematurely Ended) HU (Completed) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004674-27 | Sponsor Protocol Number: 14076 | Start Date*: 2007-02-14 | |||||||||||
Sponsor Name:Dutch Kidney Foundation | |||||||||||||
Full Title: Effect of GM-CSF on development of antigen-specific T cell responses following hepatitis B vaccination | |||||||||||||
Medical condition: Haemodialysis patients are susceptible for infections due to a continuous mildly activated immune system. About 40% of the haemodialysis patients does not respond to the standard HBV vaccination pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001439-20 | Sponsor Protocol Number: 15HH2613 | Start Date*: 2015-07-30 |
Sponsor Name:Imperial College Healthcare NHS Trust and Imperial College London | ||
Full Title: A Feasibility Randomised Controlled Trial: Effects of Oral Sodium Bicarbonate Supplementation in Patients on Haemodialysis | ||
Medical condition: End stage renal disease and metabolic acidosis with renal replacement therapy of haemodialysis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024449-65 | Sponsor Protocol Number: 159:2010/526806 | Start Date*: 2011-02-22 | |||||||||||
Sponsor Name:Västerbottens läns landsting | |||||||||||||
Full Title: Will there be lipid changes during dialysis with Citrasate as dialysate compared to conventional dialysis. | |||||||||||||
Medical condition: Chronic haemodialysis patients 18 years upwards. Patients should be in a stable condition during their chronic dialysis program (no ongoing infections or active extensive tumour with CRP above 30 m... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001267-11 | Sponsor Protocol Number: Jens05 | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Department of Nephrology | |||||||||||||
Full Title: Saving residual kidney function among haemodialysis patients receiving irbesartan - a double blind randomised study | |||||||||||||
Medical condition: We want to investigate if an angiotensin II antagonist (irbesartan) has beneficial effects regarding residual kidney function and heart/vessels among haemodialysis patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005021-60 | Sponsor Protocol Number: 01 | Start Date*: 2007-04-16 |
Sponsor Name:Prof. Dr. R. Kreutz Leiter der Abteilung Klinische Pharmakologie der Charite Berlin | ||
Full Title: Monozentrische, randomisierte, einfach verblindete, Placebo kontrollierte Studie im Cross over Design zur Untersuchung der Wirkung von Telmisartan (Kinzalmono 80 mg) auf Blutdruck und Endothelfunkt... | ||
Medical condition: Treatment of hypertension and endothelial dysfunction with Telmisartan in patients with haemodialysis due to chronic renal failure. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021665-68 | Sponsor Protocol Number: Citrasate01 | Start Date*: 2010-10-06 | ||||||||||||||||
Sponsor Name:University Hospital Antwerp | ||||||||||||||||||
Full Title: Comparison of Slow Efficiency dialysis (SLEDD) with Unfractionated Heparin versus Citrasate in Critically Ill Patients | ||||||||||||||||||
Medical condition: To compare the feasability, safety and efficacy of Sustained Slow Efficiency Dialys (SLEDD) using regional anticoagulation with Citrasate compared to systemic anticoagulation with Unfractionated He... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010437-50 | Sponsor Protocol Number: GABAPRURE01/09 | Start Date*: 2009-04-02 |
Sponsor Name:AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA | ||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF DIFFERENT GABAPENTIN DOSES IN HAEMODIALYSIS PATIENTS WITH UREMIC PRURITUS. | ||
Medical condition: Haemodialysis subjects with uremic itch. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000177-22 | Sponsor Protocol Number: TRI 50c-01/02/001 | Start Date*: 2004-12-02 | |||||||||||
Sponsor Name:TRIGEN | |||||||||||||
Full Title: An open-label, multi-centre, Phase IIa study to evaluate the safety, tolerability, pharmacodynamic efficacy and dose-related pharmacokinetics of titrated doses of the intravenous thrombin inhibitor... | |||||||||||||
Medical condition: Chronic renal failure in patients undergoing chronic haemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005746-39 | Sponsor Protocol Number: IH 001 (ACT 2) | Start Date*: 2006-02-21 |
Sponsor Name:Ineos Healthcare Ltd | ||
Full Title: A multicentre Phase II study with Alpharen™: an open-label, dose-ranging phase followed by a placebo-controlled, double-blind, parallel-group comparison in haemodialysis subjects with hyperphosphat... | ||
Medical condition: Hyperphosphataemia in haemodialysis subjects | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002488-40 | Sponsor Protocol Number: LIPMAT | Start Date*: 2015-11-06 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation | |||||||||||||
Medical condition: Nonmaturation of arteriovenous vascular accesses for hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002380-90 | Sponsor Protocol Number: IVN3DIALYSE | Start Date*: 2005-09-26 |
Sponsor Name:Nyremedicinsk afdeling, Aalborg Sygehus | ||
Full Title: Effekten af intravenøs infusion af n-3 polyumættede fedtsyrer på risikomarkører for pludselig hjertedød hos hæmodialysepatienter | ||
Medical condition: Chronic renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004993-25 | Sponsor Protocol Number: LIDPR25VER | Start Date*: 2013-01-10 |
Sponsor Name:Verisfield (UK) Ltd | ||
Full Title: A multicenter, randomized, patient-blind, investigator-blind, placebo-controlled, crossover study of Lidocaine + Prilocaine/Verisfield (2.5+2.5)% w/w cream and EMLA/AstraZeneca cream, in patients u... | ||
Medical condition: Pain related to the cannulation of arteriovenous fistula cannulation in haemodialysis patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019984-12 | Sponsor Protocol Number: AMNCH-TCD-CHG-1-2010 | Start Date*: 2010-07-21 |
Sponsor Name:Adelaide & Meath Hospital, incorporating The National Children's Hospital | ||
Full Title: A multicentre randomised trial comparing the effects of 2% chlorhexidine gluconate in 70% isopropyl alcohol as a skin, exit site and catheter hub cleansing agent versus other forms of chlorhexidine... | ||
Medical condition: Prevention of central venous catheter-related infections in haemodialysis patients. This trial will evaluate the effectiveness of 2% chlorhexidine gluconate in 70%isopropyl alcohol as a skin, exit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002681-32 | Sponsor Protocol Number: 20018510 | Start Date*: 2023-08-16 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Lumasiran in hyperoxalaemic patients on haemodialysis | ||
Medical condition: Hyperoxalaemia in patients with End Stage Kidney Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004053-10 | Sponsor Protocol Number: HN014/HBV-001 | Start Date*: 2006-02-02 |
Sponsor Name:Henogen | ||
Full Title: A phase III, multicentric, multinational, controlled, randomised, open study comparing the immunogenicity, reactogenicity and safety of Henogen’s new adjuvanted hepatitis B vaccine, HB-AS02V, admin... | ||
Medical condition: hepatitis B naïve pre-dialysis, peritoneal dialysis and haemodialysis patients from 15 years of age | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014868-19 | Sponsor Protocol Number: AKTN06.01 | Start Date*: 2011-08-19 | ||||||||||||||||
Sponsor Name:Australian Kidney Trials Network, University of Queensland | ||||||||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, factorial-design trial to assess the effect of aspirin & fish oil in the prevention of early thrombosis in arterio-venous fistulae in patients with S... | ||||||||||||||||||
Medical condition: Prevention of early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001185-17 | Sponsor Protocol Number: IH 002 | Start Date*: 2006-05-26 | |||||||||||
Sponsor Name:Ineos Healthcare Ltd | |||||||||||||
Full Title: A long-term, open-label continuation study to assess the safety of Alpharen™ in haemodialysis subjects with hyperphosphataemia. | |||||||||||||
Medical condition: Hyperphosphataemia in haemodialysis subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004012-31 | Sponsor Protocol Number: RD 5130-009-07 | Start Date*: 2009-07-06 | |||||||||||
Sponsor Name:Derby Hospitals NHS Foundation Trust [...] | |||||||||||||
Full Title: The effects of improving oxygen concentration in the reduction of dialysis induced myocardial stunning – A pilot study | |||||||||||||
Medical condition: Chronic renal failure patients who are receiving haemodialysis treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.